NORWOOD, Mass., Feb. 13, 2017 -- Xcerra Corporation (NASDAQ:XCRA), today announced the Company will release financial results for its second fiscal quarter ended January 31, 2017, on Tuesday, February 21st, before the market opens. A conference call will follow at 10:00 a.m. EST to discuss the Company’s second quarter fiscal 2017 financial results and provide third quarter fiscal 2017 guidance.
The conference call may be accessed via telephone by dialing 877.853.5334. The call will be simulcast via the Xcerra web site http://xcerra.com/investors/events-presentations/. Audio replays of the call can be heard through February 24, 2017, via telephone, by dialing 855.859.2056; conference ID number 66523985. A replay of the webcast can be accessed by visiting our web site 90 minutes following the conference call at http://xcerra.com/investors/events-presentations/.
About Xcerra
Xcerra Corporation is comprised of four businesses in the semiconductor and electronics manufacturing test markets: atg-Luther & Maelzer, Everett Charles Technologies, LTX-Credence and Multitest. The combination of these businesses creates a company with a broad spectrum of semiconductor and PCB test expertise that drives innovative new products and services, and the ability to deliver to customers fully integrated semiconductor test cell solutions. The Company addresses the broad, divergent requirements of the mobility, industrial, automotive and consumer end markets, offering a comprehensive portfolio of solutions and technologies, and a global network of strategically deployed applications and support resources. Additional information can be found at www.xcerra.com or at each product group’s website; www.atg-lm.com, www.ectinfo.com, www.ltxc.com and www.multitest.com
Xcerra is a trademark of Xcerra Corporation.
All other trademarks are the property of their respective owners.
Investor Contact: Richard Yerganian, Vice President, Investor Relations Xcerra Corporation Tel. 781.467.5063 Email [email protected]


Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 



